KEVIN OCONNOR Insider Trading $AMRI ALBANY MOLECULAR RESEARCH INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for KEVIN OCONNOR.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KEVIN OCONNOR. KEVIN OCONNOR is Director in ALBANY MOLECULAR RESEARCH INC ($AMRI).
KEVIN OCONNOR in ALBANY MOLECULAR RESEARCH INC
Trading Symbol: AMRIIndustry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of KEVIN OCONNOR: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Sep 05 2017
$AMRI Market Capitalization: $765.67M
$AMRI Previous Close: $18.44
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of KEVIN OCONNOR in ALBANY MOLECULAR RESEARCH INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | D | 18.41 | 9,358 | 172,281 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | D | 15.77 | 6,540 | 103,136 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | D | 17.05 | 6,881 | 117,321 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | D | 10.43 | 7,201 | 75,106 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | D | 5.99 | 12,367 | 74,078 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | D | 2.59 | 10,000 | 25,900 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | D | 5.28 | 10,000 | 52,800 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | D | 6.15 | 10,000 | 61,500 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | D | 8.81 | 10,000 | 88,100 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | D | 9.19 | 5,000 | 45,950 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | D | 13.54 | 5,000 | 67,700 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Sell | D | 21.75 | 58,275 | 1,267,481 | 0 | 58.3 K to 0 (-100.00 %) |
May 26 2017 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | M | 14.47 | 5,000 | 72,350 | 0 | |
May 26 2017 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Buy | M | 14.47 | 5,000 | 72,350 | 58,275 | 53.3 K to 58.3 K (+9.39 %) |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | A | 18.41 | 9,358 | 172,281 | 9,358 | |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Grant | A | 0.00 | 3,802 | 0 | 53,275 | 49.5 K to 53.3 K (+7.68 %) |
Jun 16 2016 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Grant | A | 14.82 | 1,518 | 22,497 | 49,473 | 48 K to 49.5 K (+3.17 %) |
Jun 01 2016 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | M | 10.37 | 5,000 | 51,850 | 0 | |
Jun 01 2016 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Sell | S | 14.41 | 5,000 | 72,050 | 47,955 | 53 K to 48 K (-9.44 %) |
Jun 01 2016 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Buy | M | 10.37 | 5,000 | 51,850 | 52,955 | 48 K to 53 K (+10.43 %) |
Feb 08 2016 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | A | 15.77 | 6,540 | 103,136 | 6,540 | |
Feb 08 2016 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Grant | A | 15.77 | 2,854 | 45,008 | 47,955 | 45.1 K to 48 K (+6.33 %) |
Jun 15 2015 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Grant | A | 19.98 | 2,252 | 44,995 | 45,101 | 42.8 K to 45.1 K (+5.26 %) |
Mar 13 2015 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | M | 11.85 | 5,000 | 59,250 | 0 | |
Mar 13 2015 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Sell | S | 18.22 | 5,000 | 91,100 | 42,849 | 47.8 K to 42.8 K (-10.45 %) |
Mar 13 2015 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Buy | M | 11.85 | 5,000 | 59,250 | 47,849 | 42.8 K to 47.8 K (+11.67 %) |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | A | 17.05 | 6,881 | 117,321 | 6,881 | |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Grant | A | 17.05 | 2,639 | 44,995 | 42,849 | 40.2 K to 42.8 K (+6.56 %) |
Feb 28 2014 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | M | 12.85 | 5,000 | 64,250 | 0 | |
Feb 28 2014 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Buy | M | 12.85 | 5,000 | 64,250 | 40,210 | 35.2 K to 40.2 K (+14.20 %) |
Feb 06 2014 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | A | 10.43 | 7,201 | 75,106 | 7,201 | |
Feb 06 2014 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Grant | A | 10.43 | 3,356 | 35,003 | 35,210 | 31.9 K to 35.2 K (+10.54 %) |
Jun 06 2013 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Grant | A | 10.46 | 1,434 | 15,000 | 31,854 | 30.4 K to 31.9 K (+4.71 %) |
Feb 04 2013 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | A | 5.99 | 12,367 | 74,078 | 12,367 | |
Feb 04 2013 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Grant | A | 5.99 | 5,843 | 35,000 | 30,420 | 24.6 K to 30.4 K (+23.77 %) |
Jun 14 2012 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | A | 2.59 | 10,000 | 25,900 | 10,000 | |
Jun 07 2012 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Grant | A | 2.41 | 6,224 | 15,000 | 24,577 | 18.4 K to 24.6 K (+33.91 %) |
Jun 09 2011 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | A | 5.28 | 10,000 | 52,800 | 10,000 | |
Jun 03 2011 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Grant | A | 5.14 | 3,891 | 20,000 | 18,353 | 14.5 K to 18.4 K (+26.90 %) |
Jun 04 2010 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | A | 6.15 | 10,000 | 61,500 | 10,000 | |
Jun 04 2010 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Grant | A | 6.15 | 2,439 | 15,000 | 14,462 | 12 K to 14.5 K (+20.29 %) |
Jun 04 2009 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | A | 8.81 | 10,000 | 88,100 | 10,000 | |
Jun 04 2009 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Grant | A | 8.81 | 1,702 | 14,995 | 12,023 | 10.3 K to 12 K (+16.49 %) |
Nov 21 2008 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | A | 9.19 | 1,667 | 15,320 | 5,000 | |
Nov 21 2008 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | A | 9.19 | 1,666 | 15,311 | 3,333 | |
Nov 21 2008 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | A | 9.19 | 1,667 | 15,320 | 1,667 | |
Jun 13 2008 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | A | 13.54 | 1,667 | 22,571 | 5,000 | |
Jun 13 2008 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | A | 13.54 | 1,666 | 22,558 | 3,333 | |
Jun 13 2008 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | A | 13.54 | 1,667 | 22,571 | 1,667 | |
Nov 21 2007 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Buy | P | 12.81 | 710 | 9,095 | 10,321 | 9.6 K to 10.3 K (+7.39 %) |
Nov 21 2007 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Buy | P | 12.79 | 483 | 6,178 | 9,611 | 9.1 K to 9.6 K (+5.29 %) |
Nov 21 2007 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Buy | P | 12.58 | 1,025 | 12,895 | 9,128 | 8.1 K to 9.1 K (+12.65 %) |
Jun 06 2007 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | A | 14.47 | 1,667 | 24,121 | 5,000 | |
Jun 06 2007 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | A | 14.47 | 1,666 | 24,107 | 3,333 | |
Jun 06 2007 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | A | 14.47 | 1,667 | 24,121 | 1,667 | |
Jun 06 2007 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Grant | A | 14.47 | 1,037 | 15,005 | 8,103 | 7.1 K to 8.1 K (+14.68 %) |
Jul 19 2006 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | A | 10.37 | 1,667 | 17,287 | 5,000 | |
Jul 19 2006 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | A | 10.37 | 1,666 | 17,276 | 3,333 | |
Jul 19 2006 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | A | 10.37 | 1,667 | 17,287 | 1,667 | |
Jun 02 2006 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Grant | A | 10.37 | 964 | 9,997 | 6,584 | 5.6 K to 6.6 K (+17.15 %) |
May 20 2005 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | A | 11.85 | 1,667 | 19,754 | 5,000 | |
May 20 2005 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | A | 11.85 | 1,666 | 19,742 | 3,333 | |
May 20 2005 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | A | 11.85 | 1,667 | 19,754 | 1,667 | |
May 20 2005 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Buy | P | 11.85 | 1,687 | 19,991 | 5,620 | 3.9 K to 5.6 K (+42.89 %) |
Jun 10 2004 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Buy | P | 12.85 | 778 | 9,997 | 3,933 | 3.2 K to 3.9 K (+24.66 %) |
May 21 2004 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | A | 12.85 | 1,666 | 21,408 | 5,000 | |
May 21 2004 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | A | 12.85 | 1,667 | 21,421 | 0 | |
May 21 2004 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | A | 12.85 | 1,667 | 21,421 | 0 |
Page: 1